" A NOVEL ENGINEERED SUPERANTIGEN FOR HUMAN THERAPY"
Application 2059/CHENP/2003 published 2006-01-06, filed 2003-12-24
The present invention relates to compositions and methods of use, wherein the composition comprises a conjugate of a bacterial superantigen and an antibody moiety. More particularly, the bacterial superantigen has been modified to decrease seroreactivity with retained superantigen activity.
Applicant
ACTIVE BIOTECH AB
Box 724, S-220 07 Lund, SWEDEN
Inventor
International Info
Classification: A61K 39/395, 47/48, C07K 14/31, 16/30, 19/00
Publication Number: PCT/SE02/01188
Priority Information
0102327-4 SWEDEN 2001-06-28